This announcement is a separate document:
恒瑞医药关于公司药物获得美国FDA快速通道资格的公告
Hengrui Pharmaceutical's Announcement on the Company's Drug Obtaining Fast Track Qualification from the US FDA
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.